Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
Latest Information Update: 03 Oct 2021
At a glance
- Drugs PT 20 (Primary)
- Indications Hypophosphataemia
- Focus Registrational; Therapeutic Use
- Acronyms PEACH
- Sponsors Phosphate Therapeutics
- 11 Jul 2020 Results published in the Nephrology Dialysis Transplantation
- 07 May 2015 Primary endpoint has been met (To assess the effect of oral PT20 over placebo on serum phosphate) according to a Phosphate Therapeutics media release.
- 07 May 2015 Results published in the Phosphate Therapeutics Media Release.